first trust dsip 4th quarter 17 2025 PSIP and Payment Report as of 27 January 2026 2024 D Dr Mary Edwards

Benefits include: Average weight loss of up to 15 to 25% in clinical studies Improved portion control and satiety Support for balancing blood sugar and metabolic health GLP-1/GIP Dual Agonists These advanced options activate both GLP-1 and GIP (gastric inhibitory polypeptide) receptors for enhanced appetite control, glucose balance, and fat metabolism

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

Antimicrobial peptides in host defense against drug-resistant bacterial and viral infections

Those who have a good, healthy level of vitamin B12 have fewer of the amino acid homocysteine

These inflammatory mediators further damage neurons and disrupt the BBB, allowing peripheral immune cells to infiltrate the CNS ( The interaction between excitotoxicity and neuroinflammation is critical for the development of long-term neurodegeneration